Results 281 to 290 of about 2,076,755 (337)

Pain Flare After Single Fraction Radiotherapy for Symptomatic Bone Metastases-Do We Have a Predictive Model? [PDF]

Cancer Med
Arsenijević T, Stepanović A, Bogićević S, Gržetić D, Nikitović M.   +4 more
europepmc   +1 more source

Impact of Bone Metastases and Actionable Genetic Alterations in Biliary Tract Cancer. [PDF]

Cancers (Basel)
El-Shakankery KH, Kefas J, Andaleeb R, Muehlschlegel P, Bridgewater J.   +4 more
europepmc   +1 more source

Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases

Bas J. J. Bindels, Carole Mercier, Roxanne Gal, Jorrit‐Jan Verlaan, Joost J.C. Verhoeff, Piet Dirix, Piet Ost, N. Kasperts, Yvette M. van der Linden, Helena M. Verkooijen, Joanne M. van der Velden   +10 more
openalex   +1 more source

Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art. [PDF]

Cancer Metastasis Rev
Gueiderikh A, Faivre JC, Golfier C, Escande A, Thureau S.   +4 more
europepmc   +1 more source

Context-level machine learning to improve the identification of lymph node and bone metastases in prostate cancer patients using [¹⁸F]PSMA-1007 PET. [PDF]

EJNMMI Phys
Poelarends RJ, van Dalen JA, Vendel BN, Stevens H, van Dijk JD.   +4 more
europepmc   +1 more source

Prognostic Factors in EGFR Mutation-positive Patients With Bone Metastases from Lung Adenocarcinoma. [PDF]

Cancer Diagn Progn
Osaka S, Kawashima J, Kaguchi R, Toda N, Kisohara A, Kan S, Tagawa K, Kojima T, Nagai T, Osaka E, Nakanishi K, Tanaka Y.   +11 more
europepmc   +1 more source

Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers. [PDF]

Medicina (Kaunas)
Oyucu Orhan S, Orhan B, Esenbuğa Ş, Sali S, Caner B, Ocak B, Şahin AB, Deligönül A, Evrensel T, Çubukçu E.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial

Journal of Clinical Oncology, 2023
PURPOSE External-beam radiation therapy (RT) is standard of care (SOC) for pain relief of symptomatic bone metastases. We aimed to evaluate the efficacy of radiation to asymptomatic bone metastases in preventing skeletal-related events (SRE).
E. Gillespie, Joanna C. Yang, N. Mathis, Catherine B. Marine, C. White, Zhigang Zhang, C. Barker, R. Kotecha, A. McIntosh, Max Vaynrub, M. Bartelstein, A. Mitchell, D. Guttmann, D. Yerramilli, D. Higginson, Y. Yamada, Z. Kohutek, S. Powell, J. Tsai, Jonathan T Yang   +19 more
semanticscholar   +1 more source

Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

bioRxiv, 2020
Bone metastases are devastating complications of cancer. They are particularly common in prostate cancer, represent incurable disease and are refractory to immunotherapy.
Y. Kfoury, Ninib Baryawno, N. Severe, S. Mei, K. Gustafsson, Taghreed Hirz, Thomas Brouse, Elizabeth W. Scadden, Anna A. Igolkina, Konstantinos D. Kokkaliaris, Bryan D Choi, Nikolas Barkas, M. Randolph, John H. Shin, P. Saylor, D. Scadden, D. Sykes, P. Kharchenko   +17 more
semanticscholar   +1 more source

Bone Metastases

The Cancer Journal
Abstract Bone metastases occur frequently in common malignancies such as breast and prostate cancer. They are responsible for considerable morbidity and skeletal-related events. Fortunately, there are now several systemic, focal, and targeted therapies that can improve quality and length of life, including radionuclide therapies.
Gary J R, Cook, Matthew P, Thorpe
  +5 more sources